X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect
- PMID: 2563352
- DOI: 10.1016/0888-7543(89)90315-7
X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect
Abstract
Recently developed techniques for the direct analysis of DNA have made possible the determination of patterns of cellular X-chromosome inactivation. These techniques provide a potential method for carrier detection for several X-linked human disorders in which obligate carriers show nonrandom X inactivation. By using restriction fragment length polymorphic (RFLP) gene-specific probes in conjunction with methylation-sensitive enzymes, we have characterized the patterns of X-chromosome inactivation in cell subsets from females belonging to 10 kindreds segregating for the X-linked immune deficiency disorder Wiskott-Aldrich syndrome (WAS). We show that selective inactivation of the X chromosome distinguishes obligate WAS carriers from noncarrier females and constitutes a valuable marker of the WAS carrier state. Selective inactivation phenomena were observed in the monocytes and T and B lymphocytes of obligate carriers, implying that the WAS gene defect is expressed in each of these cellular lineages. In conjunction with the use of linked DNA markers, RFLP-methylation analysis should render carrier detection feasible for the majority of females from WAS families. The results of such analyses also provide an initial step toward identifying the cellular level and molecular basis for WAS.
Similar articles
-
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.Hum Genet. 1991 Dec;88(2):237-41. doi: 10.1007/BF00206081. Hum Genet. 1991. PMID: 1684569
-
Carrier detection in the Wiskott Aldrich syndrome.Blood. 1988 Nov;72(5):1735-9. Blood. 1988. PMID: 3263154
-
Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.Hum Genet. 1992 May;89(2):223-8. doi: 10.1007/BF00217127. Hum Genet. 1992. PMID: 1350264 Clinical Trial.
-
Wiskott-Aldrich syndrome: new molecular and biochemical insights.J Am Acad Dermatol. 1992 Oct;27(4):507-19. doi: 10.1016/0190-9622(92)70215-2. J Am Acad Dermatol. 1992. PMID: 1401301 Review.
-
X chromosome linked immunodeficiency.Immunodefic Rev. 1990;2(3):233-51. Immunodefic Rev. 1990. PMID: 1981831 Review.
Cited by
-
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.Hum Genet. 1991 Dec;88(2):237-41. doi: 10.1007/BF00206081. Hum Genet. 1991. PMID: 1684569
-
Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.Clin Exp Immunol. 1991 May;84(2):219-22. Clin Exp Immunol. 1991. PMID: 1709069 Free PMC article.
-
Genetics of human X-linked immunodeficiency diseases.Clin Exp Immunol. 1991 Aug;85(2):182-92. doi: 10.1111/j.1365-2249.1991.tb05702.x. Clin Exp Immunol. 1991. PMID: 1863997 Free PMC article. Review. No abstract available.
-
X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.Ann Hematol. 1991 Aug;63(2):107-10. doi: 10.1007/BF01707282. Ann Hematol. 1991. PMID: 1912030
-
Actin cytoskeletal defects in immunodeficiency.Immunol Rev. 2013 Nov;256(1):282-99. doi: 10.1111/imr.12114. Immunol Rev. 2013. PMID: 24117828 Free PMC article. Review.